XPH Holdings Information

XPH is an equity ETF with a total of 60 individual holdings. The top holdings are Enliven Therapeutics stock at 2.40%, Terns Pharmaceuticals at 2.28%, Corcept Therapeutics at 2.28%, Innoviva at 2.06%, and Pacira BioSciences at 2.05%.

Total Holdings

Top 10 Percentage

21.22%

Asset Class

Equity

ETF Category

Health

Assets

295.95M

PE Ratio

16.73

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ELVN	Enliven Therapeutics, Inc.	2.40%	192,297
2	TERN	Terns Pharmaceuticals, Inc.	2.28%	126,197
3	CORT	Corcept Therapeutics Incorporated	2.28%	174,971
4	INVA	Innoviva, Inc.	2.06%	263,314
5	PCRX	Pacira BioSciences, Inc.	2.05%	258,586
6	PFE	Pfizer Inc.	2.05%	216,247
7	MRK	Merck & Co., Inc.	2.05%	50,800
8	AXSM	Axsome Therapeutics, Inc.	2.03%	37,013
9	ELAN	Elanco Animal Health Incorporated	2.01%	251,749
10	JNJ	Johnson & Johnson	2.01%	24,295
11	BMY	Bristol-Myers Squibb Company	2.01%	98,425
12	RPRX	Royalty Pharma plc	2.00%	126,441
13	PRGO	Perrigo Company plc	2.00%	601,785
14	JAZZ	Jazz Pharmaceuticals plc	1.99%	31,838
15	ESPR	Esperion Therapeutics, Inc.	1.97%	2,194,800
16	EWTX	Edgewise Therapeutics, Inc.	1.97%	190,497
17	ZTS	Zoetis Inc.	1.96%	49,282
18	ANIP	ANI Pharmaceuticals, Inc.	1.95%	77,382
19	TARS	Tarsus Pharmaceuticals, Inc.	1.93%	84,481
20	AMRX	Amneal Pharmaceuticals, Inc.	1.89%	464,477
21	DFTX	Definium Therapeutics, Inc.	1.89%	316,882
22	TRVI	Trevi Therapeutics, Inc.	1.89%	494,432
23	HRMY	Harmony Biosciences Holdings, Inc.	1.88%	205,054
24	VTRS	Viatris Inc.	1.87%	422,585
25	SUPN	Supernus Pharmaceuticals, Inc.	1.87%	110,926

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Mar 30, 2026